Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease

Transplant Immunology

Volumn 24, Issue 2, 2011, Pages 100-106

  Merlin, E ^a,b   Goncalves Mendes, N ^a   Hannani, D ^b,d,e   de la Torre, A ^c   Farges, M C ^c   Laroye, H ^f   Demeocq, F ^a,b   Kanold, J ^a,b   Vasson, M P ^c  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d UNIV GRENOBLE ALPES   (France)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

^f Departement d'Anatomopathologie   (France)

Author keywords

Amino acids; Apoptosis; Bone marrow transplantation; Cytokines; ECP; Nitric Oxide; PBMC Arginine

Indexed keywords

ARGINASE 1; ARGININE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; MESSENGER RNA; METHOXSALEN; NITRIC OXIDE; ORNITHINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AMINO ACID SYNTHESIS; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; EXTRACORPOREAL PHOTOCHEMOTHERAPY; FEMALE; GENE EXPRESSION REGULATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SIGNAL TRANSDUCTION; THERAPY EFFECT; ULTRAVIOLET A RADIATION; UPREGULATION;

ADOLESCENT; ADULT; ARGINASE; ARGININE; CELLS, CULTURED; CHILD; ENZYME INDUCTION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ORNITHINE; PHOTOPHERESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650309493     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.10.007     Document Type: Article

References (50)

1. Heshmati F. History of ECP. Extracorporeal Photochemotherapy and Transfusion Medicine 2008, Help Medical, Paris.
2. Edelson R.L. Photopheresis: a new therapeutic concept. Yale J Biol Med 1989, 62:565-577.
3. Hannani D., Gabert F., Laurin D., Sall M., Molens J., Hequet O., Chaperot L., Plumas J. Photochemotherapy induces the apoptosis of monocytes without impairing their function. Transplantation 2010, 89:492-499.
4. Maeda A., Schwarz A., Kernebeck K., Gross N., Aragane Y., Peritt D., Schwarz T. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005, 174:5968-5976.
5. Di Renzo M., Rubegni P., Pasqui A.L., Pompella G., De Aloe G., Sbano P., Cuccia A., Castagnini C., Auteri A., Laghi Pasini F., Fimiani M. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease. Br J Dermatol 2005, 153:59-65.
6. Maeda A., Schwarz A., Bullinger A., Morita A., Peritt D., Schwarz T. Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J Immunol 2008, 181:5956-5962.
7. Wiswedel I., Grundmann J.U., Hirsch D., Gollnick H. Detection of enhanced monohydroxyeicosatetraenoic acid and F2-isoprostane levels in human plasma samples after extracorporeal photoimmunotherapy. Skin Pharmacol Appl Skin Physiol 2003, 16:372-378.
8. Filipovich A.H., Weisdorf D., Pavletic S., Socie G., Wingard J.R., Lee S.J., Martin P., Chien J., Przepiorka D., Couriel D., Cowen E.W., Dinndorf P., Farrell A., Hartzman R., Henslee-Downey J., Jacobsohn D., McDonald G., Mittleman B., Rizzo J.D., Robinson M., Schubert M., Schultz K., Shulman H., Turner M., Vogelsang G., Flowers M.E. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
9. Toubai T., Sun Y., Reddy P. GVHD pathophysiology: is acute different from chronic?. Best Pract Res Clin Haematol 2008, 21:101-117.
10. Ferrara J.L., Cooke K.R., Teshima T. The pathophysiology of acute graft-versus-host disease. Int J Hematol 2003, 78:181-187.
11. Socie G., Blazar B.R. Acute graft-versus-host disease: from the bench to the bedside. Blood 2009, 114:4327-4336.
12. Martin P.J. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med 2008, 57:177-183.
13. Moinard C., Caldefie F., Walrand S., Felgines C., Vasson M.P., Cynober L. Involvement of glutamine, arginine, and polyamines in the action of ornithine alpha-ketoglutarate on macrophage functions in stressed rats. J Leukoc Biol 2000, 67:834-840.
14. Ochoa J.B., Strange J., Kearney P., Gellin G., Endean E., Fitzpatrick E. Effects of L-arginine on the proliferation of T lymphocyte subpopulations. JPEN J Parenter Enteral Nutr 2001, 25:23-29.
15. Rodriguez P.C., Quiceno D.G., Ochoa A.C. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007, 109:1568-1573.
16. Zea A.H., Rodriguez P.C., Atkins M.B., Hernandez C., Signoretti S., Zabaleta J., McDermott D., Quiceno D., Youmans A., O'Neill A., Mier J., Ochoa A.C. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005, 65:3044-3048.
17. Munder M., Schneider H., Luckner C., Giese T., Langhans C.D., Fuentes J.M., Kropf P., Mueller I., Kolb A., Modolell M., Ho A.D. Suppression of T-cell functions by human granulocyte arginase. Blood 2006, 108:1627-1634.
18. Kropf P., Baud D., Marshall S.E., Munder M., Mosley A., Fuentes J.M., Bangham C.R., Taylor G.P., Herath S., Choi B.S., Soler G., Teoh T., Modolell M., Muller I. Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol 2007, 37:935-945.
19. Cynober L., Le Boucher J., Vasson M.P. Arginine metabolism in mammals. J Nutr Biochem 1995, 6:402-413.
20. Bronte V., Serafini P., Mazzoni A., Segal D.M., Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003, 24:302-306.
21. Susskind B.M., Chandrasekaran J. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine. J Immunol 1987, 139:905-912.
22. Della Bella S., Gennaro M., Vaccari M., Ferraris C., Nicola S., Riva A., Clerici M., Greco M., Villa M.L. Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer 2003, 89:1463-1472.
23. Choi I.C., Fung P.C., Leung A.Y., Lie A.K., Liang R. Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipients. Haematologica 2001, 86:972-976.
24. Bobe P., Benihoud K., Grandjon D., Opolon P., Pritchard L.L., Huchet R. Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction. Blood 1999, 94:1028-1037.
25. Lee K.S., Lee W.S., Suh S.I., Kim S.P., Lee S.R., Ryoo Y.W., Kim B.C. Melatonin reduces ultraviolet-B induced cell damages and polyamine levels in human skin fibroblasts in culture. Exp Mol Med 2003, 35:263-268.
26. Glucksberg H., Storb R., Fefer A., Buckner C., Neiman P., Clift R., Lerner K. T. ED., Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
27. Shulman H., Sullivan K., Weiden P., McDonald G., Striker G., Sale G., Hackman R., Tsoi M., Storb R. T. ED., Chronic graft-versus host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
28. Kanold J., Merlin E., Halle P., Paillard C., Marabelle A., Rapatel C., Evrard B., Berger C., Stephan J.L., Galambrun C., Piguet C., D'Incan M., Bordigoni P., Demeocq F. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Transfusion 2007, 47:2276-2289.
29. Minet-Quinard R., Van Praagh I., Kwiatkowski F., Beaujon G., Feillel V., Beaufrere B., Bargnoux P.J., Cynober L., Vasson M.P. Pre- and postoperative aminoacidemia in breast cancer: a study vs. matched healthy subjects. Cancer Invest 2004, 22:203-210.
30. Berard M.P., Zazzo J.F., Condat P., Vasson M.P., Cynober L. Total parenteral nutrition enriched with arginine and glutamate generates glutamine and limits protein catabolism in surgical patients hospitalized in intensive care units. Crit Care Med 2000, 28:3637-3644.
31. Goncalves-Mendes N., Blanchon L., Meiniel A., Dastugue B., Sapin V. Placental expression of SCO-spondin during mouse and human development. Gene Expr Patterns 2004, 4:309-314.
32. Tokura Y., Seo N., Yagi H., Wakita H., Moriwaki S., Furukawa F., Takigawa M. Treatment of T lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production. J Invest Dermatol 1999, 113:202-208.
33. Bladon J., Taylor P.C. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction. Transplant Proc 2003, 35:1328-1332.
34. Craciun L.I., Stordeur P., Schandene L., Duvillier H., Bron D., Lambermont M., Goldman M., Dupont E. Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation 2002, 74:995-1000.
35. Allan S.E., Broady R., Gregori S., Himmel M.E., Locke N., Roncarolo M.G., Bacchetta R., Levings M.K. CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev 2008, 223:391-421.
36. Haddad J.J., Fahlman C.S. Redox- and oxidant-mediated regulation of interleukin-10: an anti-inflammatory, antioxidant cytokine?. Biochem Biophys Res Commun 2002, 297:163-176.
37. El-Gayar S., Thuring-Nahler H., Pfeilschifter J., Rollinghoff M., Bogdan C. Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J Immunol 2003, 171:4561-4568.
38. Biagi E., Di Biaso I., Leoni V., Gaipa G., Rossi V., Bugarin C., Renoldi G., Parma M., Balduzzi A., Perseghin P., Biondi A. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007, 84:31-39.
39. Brahmachari S., Pahan K. Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol 2009, 183:2045-2058.
40. Bansal V., Ochoa J.B. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 2003, 6:223-228.
41. Hoechst B., Ormandy L.A., Ballmaier M., Lehner F., Kruger C., Manns M.P., Greten T.F., Korangy F. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008, 135:234-243.
42. Hammerberg C., Duraiswamy N., Cooper K.D. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultraviolet-exposed epidermal cells is dependent upon infiltrating class II MHC+ CD11bbright monocytic/macrophagic cells. J Immunol 1994, 153:4915-4924.
43. Peranzoni E., Marigo I., Dolcetti L., Ugel S., Sonda N., Taschin E., Mantelli B., Bronte V., Zanovello P. Role of arginine metabolism in immunity and immunopathology. Immunobiology 2007, 212:795-812.
44. Babu S., Kumaraswami V., Nutman T.B. Alternatively activated and immunoregulatory monocytes in human filarial infections. J Infect Dis 2009, 199:1827-1837.
45. Ochoa J.B., Bernard A.C., O'Brien W.E., Griffen M.M., Maley M.E., Rockich A.K., Tsuei B.J., Boulanger B.R., Kearney P.A., Morris S.M. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg 2001, 233:393-399.
46. McGown C.C., Brookes Z.L. Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br J Anaesth 2007, 98:163-175.
47. Zhu S., Ashok M., Li J., Li W., Yang H., Wang P., Tracey K.J., Sama A.E., Wang H. Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol Med 2009, 15:275-282.
48. Deakin A., Payne A., Whittle B., Moncada S. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine 1995, 7:408-416.
49. Yu J., Sauter S., Parlesak A. Suppression of TNF-alpha production by S-adenosylmethionine in human mononuclear leukocytes is not mediated by polyamines. Biol Chem 2006, 387:1619-1627.
50. Roy J., Blazar B.R., Ochs L., Weisdorf D.J. The tissue expression of cytokines in human acute cutaneous graft-versus-host disease. Transplantation 1995, 60:343-348.